Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05402696 · ClinicalTrials.gov registry record
St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)
A clinical trial, sponsored by University of British Columbia.
- Recruiting
- Registry status
- 3,500
- Enrollment target
NCT05402696: Recruiting study, sponsored by University of British Columbia.
NCT05402696 is a clinical trial that is actively recruiting participants, run by University of British Columbia. The registered enrollment target is 3,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05402696 is actively recruiting participants, sponsored by University of British Columbia.
- RECRUITING
- Registry status
- 3,500 participants
- Enrollment target
Study Summary
The SPARC-C study is a prospective, multi-institutional observational study of patients referred for the management of large (≥ 20mm) non-pedunculated colorectal polyps (LNPCPs). Patients are managed consistent with current standards of care. Prospectively collected data includes: patient clinicodemographic details, lesion details, procedural details, and clinical outcomes.
Primary Outcome
Complete removal of all visible polypoid tissue during index procedure.
Interventions
- PROCEDURE Endoscopic tissue resection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,500 participants |
| Start Date | 2022-06-27 |
| Est. Completion | 2032-12-31 |
What NCT05402696 shows while recruiting
NCT05402696 is an observational study that tracks outcomes without assigning an intervention. Its 3,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Endoscopic tissue resection is the first listed.
NCT05402696 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05402696 about?
NCT05402696 is a clinical study titled "St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)". The SPARC-C study is a prospective, multi-institutional observational study of patients referred for the management of large (≥ 20mm) non-pedunculated colorectal polyps (LNPCPs). Patients are managed consistent with current standards of care. Prospectively collected data includes: patient clinicodem...
What is the current status of trial NCT05402696?
This trial is currently recruiting. The enrollment target is 3,500 participants. The study started on 2022-06-27. Estimated completion is 2032-12-31.
What interventions are being tested in trial NCT05402696?
The interventions under investigation include: Endoscopic tissue resection (PROCEDURE).
Who is sponsoring clinical trial NCT05402696?
This trial is sponsored by University of British Columbia, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260559 · 3,500 participants
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
- NCT01612949 · 3,500 participants
Facial Analysis to Classify Difficult Intubation
- NCT02398786 · 3,500 participants
Myotonic Dystrophy Family Registry
- NCT03486873 · 3,500 participants · Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI